In the quetiapine-carbamazepine interaction, quetiapine is reduced by 50% and what happens to carbamazepine levels?

Prepare for the Schizophrenia and Psychotic Disorders Test with interactive questions and detailed explanations. Equip yourself with the knowledge needed to excel in your exam!

Multiple Choice

In the quetiapine-carbamazepine interaction, quetiapine is reduced by 50% and what happens to carbamazepine levels?

Explanation:
The key idea is a drug–drug interaction driven by enzyme induction, specifically CYP3A4. Carbamazepine is a strong inducer of CYP3A4, which metabolizes quetiapine. When they’re used together, the induction speeds up quetiapine’s metabolism, so quetiapine levels drop—often by about half. Carbamazepine itself is affected by this environment too, but the induction effect on quetiapine does not substantially suppress carbamazepine. In clinical scenarios like this, carbamazepine levels can show only minor changes, and in some cases may appear slightly increased. So the best-supported statement is that carbamazepine levels are slightly increased.

The key idea is a drug–drug interaction driven by enzyme induction, specifically CYP3A4. Carbamazepine is a strong inducer of CYP3A4, which metabolizes quetiapine. When they’re used together, the induction speeds up quetiapine’s metabolism, so quetiapine levels drop—often by about half.

Carbamazepine itself is affected by this environment too, but the induction effect on quetiapine does not substantially suppress carbamazepine. In clinical scenarios like this, carbamazepine levels can show only minor changes, and in some cases may appear slightly increased. So the best-supported statement is that carbamazepine levels are slightly increased.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy